SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
Daniel Mrak, Selma Tobudic, Maximilian Koblischke, Marianne Graninger, Helga Radner, Daniela Sieghart, Philipp Hofer, Thomas Perkmann, Helmuth Haslacher, Renate Thalhammer, Stefan Winkler, Stephan Blüml, Karin Stiasny, Judith H. Aberle, Josef S Smolen, Leonhard X. Heinz, Daniel Aletaha, Michael Bonelli
Topics & Concepts
MedicineImmunologyRituximabHumoral immunityImmune systemVaccinationImmunityCell mediated immunityCellular immunityVirologyAntibodySARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCOVID-19 Clinical Research Studies